Volume 10, Number 11, November 2004

Evaluating Human Papillomavirus Vaccination Programs

Al V. Taira,* Christopher P. Neukermans,† and Gillian D. Sanders†‡
*Stanford School of Medicine, Stanford, California, USA; †Stanford University, Stanford, California, USA; and ‡Duke University, Durham, North Carolina, USA

Figure 4. Tornado diagram representing the incremental cost-effectiveness ratios of one-way sensitivity analysis on vaccinating men and women compared to vaccinating women only. The vertical line represents the incremental cost-effectiveness ratio under base-case conditions. The sensitivity analysis range is displayed in parentheses next to each variable. Unequal penetration represents potential for lower (or higher) vaccine penetration in the highest risk groups, from 30% to 80% of target group, compared to 70% penetration in base case. QALY, quality-adjusted life-year.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed October 22, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention